Goldman Sachs’s Avanos Medical AVNS Stock Holding History

Goldman Sachs’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-744	Closed	-$28K	–	6741
2016 Q4	$28K	Hold	744	–	–	﹤0.01%	6547
2016 Q3	$26K	Sell	744 -168	-18%	-$5.88K	﹤0.01%	6679
2016 Q2	$30K	Sell	912 -50,000	-98%	-$1.53M	﹤0.01%	6590
2016 Q1	$1.46M	Sell	50,912 -1,044	-2%	-$27.8K	﹤0.01%	3755
2015 Q4	$1.74M	Buy	51,956 +49,820	+2,332%	+$1.55M	﹤0.01%	3766
2015 Q3	$61K	Sell	2,136 -408	-16%	-$14.2K	﹤0.01%	6713
2015 Q2	$103K	Sell	2,544 -1,596	-39%	-$71.6K	﹤0.01%	6587
2015 Q1	$204K	Sell	4,140 -5,388	-57%	-$250K	﹤0.01%	6000
2014 Q4	$433K	Buy	+9,528	New	+$374K	﹤0.01%	5430

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Goldman Sachs's AVNS Position: Q1 2026 in Review

Goldman Sachs increased its Avanos Medical (AVNS) stake by 6.5% in Q1 2026, buying an estimated $397K and bringing the position to 480,886 shares worth $6.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

Goldman Sachs first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $99M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Goldman Sachs held 480,886 shares of Avanos Medical worth $6.74M as of Q1 2026.
Goldman Sachs bought 29,497 Avanos Medical shares in Q1 2026, an estimated $397K.
Avanos Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3413 holding.
Goldman Sachs first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
Goldman Sachs's Avanos Medical position peaked at $99M in Q3 2018.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.